BG Medicine Inc
OTC:BGMD
Income Statement
Earnings Waterfall
BG Medicine Inc
Revenue
|
1.6m
USD
|
Cost of Revenue
|
-505k
USD
|
Gross Profit
|
1.1m
USD
|
Operating Expenses
|
-5.7m
USD
|
Operating Income
|
-4.6m
USD
|
Other Expenses
|
-2.3m
USD
|
Net Income
|
-7m
USD
|
Income Statement
BG Medicine Inc
Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||
Revenue |
1
N/A
|
1
-17%
|
2
+93%
|
1
-13%
|
1
+6%
|
2
+12%
|
1
-23%
|
2
+32%
|
2
+28%
|
3
+33%
|
3
+14%
|
4
+12%
|
4
+11%
|
4
+2%
|
4
-4%
|
4
-5%
|
3
-9%
|
3
-18%
|
2
-11%
|
2
-12%
|
2
-17%
|
2
-14%
|
|
Gross Profit | |||||||||||||||||||||||
Cost of Revenue |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Gross Profit |
(0)
N/A
|
0
N/A
|
1
+2 052%
|
1
+1%
|
1
+24%
|
1
+14%
|
1
-42%
|
1
+58%
|
1
+32%
|
2
+51%
|
2
+15%
|
2
+12%
|
3
+12%
|
3
+1%
|
3
-2%
|
3
-4%
|
2
-9%
|
2
-21%
|
2
-11%
|
1
-11%
|
1
-16%
|
1
-13%
|
|
Operating Income | |||||||||||||||||||||||
Operating Expenses |
(16)
|
(15)
|
(14)
|
(15)
|
(16)
|
(19)
|
(23)
|
(24)
|
(26)
|
(25)
|
(22)
|
(21)
|
(18)
|
(17)
|
(14)
|
(11)
|
(10)
|
(9)
|
(8)
|
(8)
|
(6)
|
(6)
|
|
Selling, General & Administrative |
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(11)
|
(13)
|
(15)
|
(16)
|
(17)
|
(16)
|
(16)
|
(15)
|
(13)
|
(11)
|
(9)
|
(8)
|
(7)
|
(6)
|
(5)
|
(4)
|
(4)
|
|
Research & Development |
(8)
|
(7)
|
(6)
|
(7)
|
(7)
|
(8)
|
(9)
|
(9)
|
(10)
|
(8)
|
(6)
|
(5)
|
(3)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
Operating Income |
(16)
N/A
|
(15)
+9%
|
(13)
+12%
|
(14)
-10%
|
(16)
-10%
|
(17)
-13%
|
(22)
-26%
|
(23)
-6%
|
(25)
-7%
|
(23)
+9%
|
(20)
+12%
|
(19)
+8%
|
(15)
+17%
|
(14)
+6%
|
(12)
+20%
|
(9)
+22%
|
(8)
+13%
|
(7)
+6%
|
(7)
+9%
|
(6)
+8%
|
(5)
+20%
|
(5)
+6%
|
|
Pre-Tax Income | |||||||||||||||||||||||
Interest Income Expense |
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
Total Other Income |
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
|
Pre-Tax Income |
(18)
N/A
|
(17)
+5%
|
(15)
+14%
|
(16)
-7%
|
(16)
-2%
|
(18)
-9%
|
(22)
-26%
|
(24)
-7%
|
(26)
-8%
|
(24)
+7%
|
(22)
+10%
|
(20)
+7%
|
(17)
+16%
|
(16)
+6%
|
(13)
+20%
|
(10)
+21%
|
(9)
+13%
|
(8)
+7%
|
(7)
+10%
|
(7)
+2%
|
(6)
+19%
|
(5)
+7%
|
|
Net Income | |||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(18)
|
(17)
|
(15)
|
(16)
|
(16)
|
(18)
|
(22)
|
(24)
|
(26)
|
(24)
|
(22)
|
(20)
|
(17)
|
(16)
|
(13)
|
(10)
|
(9)
|
(8)
|
(7)
|
(7)
|
(6)
|
(5)
|
|
Net Income (Common) |
(19)
N/A
|
(18)
+5%
|
(16)
+14%
|
(16)
-5%
|
(17)
-1%
|
(18)
-7%
|
(22)
-25%
|
(24)
-7%
|
(26)
-8%
|
(24)
+7%
|
(22)
+10%
|
(20)
+7%
|
(17)
+16%
|
(16)
+6%
|
(13)
+20%
|
(10)
+21%
|
(9)
+13%
|
(8)
+7%
|
(7)
+10%
|
(7)
+2%
|
(7)
-3%
|
(7)
+5%
|
|
EPS (Diluted) |
-25.46
N/A
|
-24.49
+4%
|
-5.12
+79%
|
-3.42
+33%
|
-3.42
N/A
|
-4.01
-17%
|
-4.43
-10%
|
-4.72
-7%
|
-5.03
-7%
|
-4.7
+7%
|
-3.39
+28%
|
-2.88
+15%
|
-2.4
+17%
|
-2.33
+3%
|
-1.82
+22%
|
-1.02
+44%
|
-1.01
+1%
|
-0.99
+2%
|
-0.83
+16%
|
-0.82
+1%
|
-0.74
+10%
|
-0.72
+3%
|